Skip to content

Sections
- Health
- Pharma
- Biotech
- Hospitals
- Politics
- In the Lab
- First Opinion
- Gut Check
- The Watchdogs
Topics
Multimedia
Popular
STAT Plus

Job Board
About Us

Newsletters
My Account
- Settings
- Log Out

Newsletters
My Account
- Settings
- Log Out

Cancer

Biotech

Ignyta drug targeting rare lung cancer shows early promise, even when tumors spread to brain

By Adam Feuerstein

Health

Appeals court tosses $72 million award in talcum powder case

By Associated Press

advertisement

Health

Liquid biopsy could lead to precision therapies for children’s eye tumors

By Usha Lee McFarling

advertisement

Health

To accelerate new cancer treatments, NIH will team up with pharma on immunotherapy research

In the Lab

Meet the MacArthur ‘genius’ grant winner tracking the evolution of our cells

By Megan Thielking

In the Lab

CAR-T cancer therapy is potent, but can be lethal. New research helps explain why

By Meghana Keshavan

In the Lab

‘We have entered a new era’: Cancer researchers no longer follow a single path to discovery

By Andrew Joseph

advertisement

First Opinion

The cancer stories no one wants to hear

By Renata Louwers

advertisement

Adam's Take

How a whole lot of hype sent Endocyte’s stock soaring for no good reason

By Adam Feuerstein

Health

How beagles and goldens could help researchers find the next cancer therapy for humans

By Usha Lee McFarling

Pharma

5 ways pharma is misleading the public on the cost of prescription drugs

By Jay Hancock — Kaiser Health News

Biotech

The big names at this startup have big plans to speed drug discovery — with ‘CRISPRomics’

By Meghana Keshavan

In the Know

In his life and his work, pushing for personalized medicine to help more cancer patients

First Opinion

Overshadowed by pink: Breast cancer is important, but so are other cancers

By Tamlyn Oliver

Health

FDA approves Lilly pill for common advanced breast cancer

By Associated Press

In the Lab

With the Nobel Prizes around the corner, it’s crystal ball time

By Sharon Begley

Politics

In Congress, a doctor becomes a cancer patient — and preaches candor

By Erin Mershon

Health

As care shifts from hospital to home, guarding against infection falls to families

By Melissa Bailey — Kaiser Health News

Business

There’s only one approved CAR-T, but companies are ready to capitalize on it

By Kate Sheridan

Heavyweights

Did he really just tweet that? Dr. Vinay Prasad takes on Big Pharma, Big Medicine, and his own colleagues — with glee

By Meghana Keshavan

Morning Rounds

Test your knowledge of the week’s health news

By Megan Thielking

Business

Moderna leaves key questions unanswered as investors seek the reality behind the hype

By Damian Garde

Business

10 tidbits of investor intel — or, what Adam and Damian learned this week in New York

By Adam Feuerstein and Damian Garde

Pharmalot

Lawmakers ask CMS for details on money-back deal for pricey Novartis CAR-T drug

By Ed Silverman

Health

Cancer deaths are down — but new cases are on the rise, report says

By Megan Thielking

Health

Age matters when it comes to screening for cervical cancer

By Associated Press

Endnotes

Delivered from death by a ‘miracle,’ a survivor walks gingerly among the living

By Bob Tedeschi

In the Lab

Two U.S. scientists awarded Balzan Prize for cancer research

By Associated Press

Pharmalot

How much does it really cost to develop a cancer drug? Try $648 million

By Ed Silverman

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine.

Industry

Leave this field empty if you're human:

Sign up for our morning rounds newsletter

Leave this field empty if you're human:

Reporting from the frontiers of health and medicine

About Us
Contact Us
The STAT Team
STAT Wunderkinds
Awards for STAT
Work at STAT
Job Board
Advertise

Privacy
Comment Policy
Terms

© 2017 STAT

X